| 货号 | VK565406 |
|---|
| 产品名称 | Research Grade Anti-SARS-CoV-2 RBD (S304) |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | SARS-CoV-2 (2019-nCoV) |
|---|
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2 |
|---|
| 基因号 | P0DTC2 |
|---|
| 宿主/表达体系 | Human |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Anti-SARS-CoV-2 RBD (S304) ( VK565406 ) is a research-grade recombinant antibody targeting Spike glycoprotein . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|